700,000 seniors have reportedly started GLP-1s since Medicare obesity-drug coverage began in July

CNBC reports that Eli Lilly CEO Dave Ricks said on September 21, 2026, that 700,000 seniors had started GLP-1 treatments since Medicare coverage of obesity drugs launched in July. He said 70% of those new patients were on Lilly medicines, describing the expansion of the broader GLP-1 market as “what we had hoped.”